-
1
-
-
84858436543
-
-
Accessed December, 2011
-
FDA. 2011. Enforcement Report Home Page. http://www.fda.gov/Safety/ Recalls/EnforcementReports/default.htm Accessed December, 2011.
-
(2011)
Enforcement Report Home Page
-
-
-
2
-
-
37349108158
-
Microbial diversity in pharmaceutical product recalls and environments
-
Jimenez, L. 2007. Microbial diversity in pharmaceutical product recalls and environments. PDA Journal of Pharmaceutical Science and Technology 61(5):383-399. (Pubitemid 350305109)
-
(2007)
PDA Journal of Pharmaceutical Science and Technology
, vol.61
, Issue.5
, pp. 383-399
-
-
Jimenez, L.1
-
4
-
-
34748867409
-
The Harmonization of the Microbial Limits Tests
-
Sutton, S. 2006. The Harmonization of the Microbial Limits Tests Pharm Technol. 30(12):66-73
-
(2006)
Pharm Technol
, vol.30
, Issue.12
, pp. 66-73
-
-
Sutton, S.1
-
6
-
-
3543028306
-
Microbial Contamination of Sterile and Non-Sterile Articles, with Special Reference to Pseudomonas cepacia
-
USP.
-
USP. 1982. Microbial Contamination of Sterile and Non-Sterile Articles, with Special Reference to Pseudomonas cepacia. Pharm Forum 8(4):2239.
-
(1982)
Pharm Forum
, vol.8
, Issue.4
, pp. 2239
-
-
-
7
-
-
0034982979
-
Setting Threshold Limits for the Significance of Objectionable Microorganisms in Oral Pharmaceutical Products
-
Manu-Tawiah, W et al. 2001. Setting Threshold Limits for the Significance of Objectionable Microorganisms In Oral Pharmaceutical Products. PDA J Pharm Sci Tech. 55(3):171-175
-
(2001)
PDA J Pharm Sci Tech
, vol.55
, Issue.3
, pp. 171-175
-
-
Manu-Tawiah, W.1
-
8
-
-
0020075662
-
Bacterial Contamination of Aerosol Solutions Used to Treat Cystic Fibrosis
-
Kuhn, RJ et al. 1982. Bacterial Contamination of Aerosol Solutions Used To Treat Cystic Fibrosis. Amer J Hosp Pharm 39:308-309.
-
(1982)
Amer J Hosp Pharm
, vol.39
, pp. 308-309
-
-
Kuhn, R.J.1
-
9
-
-
0020360655
-
Factors Affecting Survival of Pseudomonas cepacia in Decongestant Nasal Sprays Containing Thimerosal as Preservative
-
Decicco, B., Lee, E., et al. 1982. Factors Affecting Survival of Pseudomonas cepacia in Decongestant Nasal Sprays Containing Thimerosal as Preservative. J Pharm Sci. 71(11):1231-1234
-
(1982)
J Pharm Sci
, vol.71
, Issue.11
, pp. 1231-1234
-
-
Decicco, B.1
Lee, E.2
-
11
-
-
83755173183
-
Burkholderia cepacia: This Decision Is Overdue
-
Torbeck, L., et al. 2011. Burkholderia cepacia: This Decision Is Overdue. PDA J Pharm Sci Tech 65(5):535-543
-
(2011)
PDA J Pharm Sci Tech
, vol.65
, Issue.5
, pp. 535-543
-
-
Torbeck, L.1
-
12
-
-
84858404458
-
Commentary on "Burkholderia cepacia: This Decision Is Overdue"
-
In Press
-
Sutton, S. 2012 Commentary on "Burkholderia cepacia: This Decision Is Overdue". PDA J Pharm Sci Tech In Press.
-
(2012)
PDA J Pharm Sci Tech
-
-
Sutton, S.1
-
13
-
-
33646241285
-
Microbial Identification Strategies in the Pharmaceutical Industry PDA J Pharm
-
Cundell, AM. 2006. Microbial Identification Strategies in the Pharmaceutical Industry PDA J Pharm Sci Tech 60(2):111-123.
-
(2006)
Sci Tech
, vol.60
, Issue.2
, pp. 111-123
-
-
Cundell, A.M.1
|